GLP-1 medicines and pregnancy can stir up a lot of worry. Maybe you are hoping to start a family soon. Maybe a pregnancy came as a surprise.
You may be taking Wegovy® or Ozempic® to reach a health goal. Now you have new questions, and you want clear answers.
You are not alone, and you have time to plan. This page walks through what the FDA labels actually say, in plain words.
Key takeaways
- The Wegovy® and Ozempic® labels tell people to stop the medicine before a planned pregnancy.
- Both labels ask for a two-month gap because semaglutide stays in the body a long time.
- Animal studies suggest a possible risk to a developing baby, so the labels urge caution.
- The Zepbound® label says to stop the medicine as soon as pregnancy is recognized.
- Bring any pregnancy plans to your prescriber early, so you can map out timing together.
- Important safety information: Wegovy®, Ozempic®, and other GLP-1 medicines carry a boxed warning about thyroid C-cell tumors.
- In animal studies, these medicines caused thyroid C-cell tumors in rodents. Whether they do this in people is not known.
- Do not use these medicines if you or a family member has had medullary thyroid cancer (MTC) or MEN 2.
- Tell your prescriber about any neck lump, swelling, trouble swallowing, or a hoarse voice that will not pass.
What this guide answers
- What do the FDA labels say about GLP-1 medicines and pregnancy?
- Why do the Wegovy® and Ozempic® labels ask for a two-month gap?
- What does animal fetal-risk data really mean for me?
- How do the Zepbound® and Mounjaro® labels differ?
- What should I do if I learn I am pregnant?
GLP-1 medicines and pregnancy: what the labels say
Every GLP-1 medicine comes with an FDA label. The label has a section just for pregnancy. It sums up what makers and regulators know so far.
The short version is simple. The labels do not recommend these medicines during pregnancy. Each brand words its guidance a little differently.
Wegovy® (brand of semaglutide) and Ozempic® (brand of semaglutide) share the same active drug. Their labels give the same core message about pregnancy.
Both labels say to stop the medicine at least two months before a planned pregnancy. That is label guidance, not a rule made for your body alone.
Your own timing can depend on many things. That is why every label points you back to your prescriber for a personal plan.
The labels do not recommend GLP-1 medicines in pregnancy. What differs by brand is the exact wording and the timing they suggest.
Why Wegovy® and Ozempic® set a two-month window
The two-month window comes down to how long the drug lingers. Semaglutide has a long half-life. That means it clears the body slowly.
Half-life is the time it takes for the drug level to fall by half. A long half-life means the medicine is still around for weeks.
Because of that slow clearing, the Wegovy® and Ozempic® labels build in a buffer. They ask for at least two months before a planned pregnancy.
The goal is to let the medicine leave your system first. This is a planning step, and it is worth mapping out early with your care team.
Only your prescriber can help you set the right dates. Do not change your own timing based on this page alone.
What "animal data suggest potential fetal risk" means
You may see a line about animal data on the label. It notes that animal studies suggest a possible risk to a developing baby.
Animal studies are how makers first check safety. Results in animals do not always match what happens in people. Still, the labels take them seriously.
Because of that signal, the labels lean toward caution. They would rather you avoid the medicine during pregnancy than take an unknown chance.
This does not mean harm is proven in people. It means the safe path, per the label, is to stop the medicine and plan ahead.
How the Zepbound® and Mounjaro® labels differ
Wegovy® and Ozempic® are not the only GLP-1 brands people ask about. Zepbound® (brand of tirzepatide) and Mounjaro® (brand of tirzepatide) come up too.
These two share a different active drug called tirzepatide. Their pregnancy wording is not the same as the semaglutide brands.
The Zepbound® label says weight loss offers no benefit during pregnancy and may cause harm. It tells people to stop the medicine when a pregnancy is recognized.
The Mounjaro® label takes a benefit-and-risk view. It says to use the medicine only if the benefit clearly justifies the risk to the pregnancy.
| Brand (active drug) | What the label says about pregnancy | Timing note |
|---|---|---|
| Wegovy® (semaglutide) | Not recommended; animal data suggest potential fetal risk | Stop at least 2 months before a planned pregnancy |
| Ozempic® (semaglutide) | Not recommended; animal data suggest potential fetal risk | Stop at least 2 months before a planned pregnancy |
| Zepbound® (tirzepatide) | Weight loss offers no benefit and may cause harm | Stop when pregnancy is recognized |
| Mounjaro® (tirzepatide) | Use only if the benefit justifies the risk | Discuss timing with your prescriber |
How each brand label frames pregnancy. Your prescriber sets your plan.
Notice the shared theme across all four brands. None is meant to help during pregnancy, and each points you toward your prescriber.
The wording differs, but the spirit is the same. These medicines and pregnancy are a topic to plan around, not to guess about.
If you learn you are pregnant while taking a GLP-1 medicine
Sometimes a pregnancy is a surprise. If that happens, try not to panic. Many people have been in the same spot.
Reach out to your prescriber as soon as you can. They can guide your next steps based on your full picture.
The Zepbound® label, for example, says to stop the medicine once a pregnancy is recognized. Your care team can confirm what your own label advises.
Do not stop or restart any medicine on your own without that call. A quick conversation helps you make a safe, calm choice.
A surprise pregnancy is not a crisis to solve alone. One early call to your prescriber turns worry into a clear next step.
Planning a pregnancy: why timing matters
If a pregnancy is part of your plan, timing is your friend. The labels build in a gap for a reason.
For Wegovy® and Ozempic®, that gap is at least two months before a planned pregnancy. Planning early gives you room to work it out.
Bring the topic up sooner rather than later. Your prescriber can look at your goals, your dose, and your calendar together with you.
Planning matters here, but the details are personal. This page cannot set your dates, and neither should a guess.
What to talk about with your prescriber
A short, honest chat with your prescriber clears up most worries. It helps to walk in with a few notes ready.
You do not need medical words. Plain questions work best. Here are a few worth raising when pregnancy is on your mind.
1. Tell your prescriber if you are planning a pregnancy or think you may be pregnant now.
2. Ask what your specific brand label says, since Wegovy®, Ozempic®, and Zepbound® word it differently.
3. Ask how the two-month window before a planned pregnancy applies to your Wegovy® or Ozempic® plan.
4. Ask what to do about your weight or health goals during any pause in the medicine.
5. Ask when and how a restart might fit your plans after pregnancy, based on your label.
Write down the answers so you can review them later. It is easy to forget details after an appointment.
You can also ask for the guidance in writing. That way your whole care team stays on the same page.
Above all, keep the conversation going. Your prescriber is your best guide for timing that fits your life.
Frequently asked questions
Can I take Wegovy® or Ozempic® while pregnant?
The Wegovy® and Ozempic® labels do not recommend these medicines during pregnancy. Both share the active drug semaglutide, and animal data suggest a possible risk to a developing baby. The labels advise stopping at least two months before a planned pregnancy. This is label guidance, not a personal plan, so talk with your prescriber about what fits your situation.
Why do the labels ask for a two-month gap?
Semaglutide has a long half-life, which means it leaves the body slowly. Because the medicine can linger for weeks, the Wegovy® and Ozempic® labels build in a buffer. They ask people to stop at least two months before a planned pregnancy so the drug can clear first. Your prescriber can help you set the right dates for your plan.
What does animal fetal-risk data mean?
Makers test new medicines in animals before people. For these GLP-1 medicines, animal studies suggested a possible risk to a developing baby. Results in animals do not always match people, but the labels take the signal seriously. That is why they lean toward caution and advise against use in pregnancy. Your prescriber can walk you through what this means for you.
What if I got pregnant while taking a GLP-1 medicine?
Try not to panic, and call your prescriber soon. The Zepbound® label, for example, says to stop the medicine once a pregnancy is recognized. Your care team can confirm what your own label advises and guide your next steps. Do not stop or restart any medicine on your own before that conversation. An early call turns worry into a clear plan.
Do the Zepbound® and Mounjaro® labels say the same thing?
Not quite. Both use the active drug tirzepatide, but the wording differs. The Zepbound® label says weight loss offers no benefit in pregnancy and may cause harm, so stop when pregnancy is recognized. The Mounjaro® label says to use it only if the benefit justifies the risk. Your prescriber can explain which guidance applies to your specific brand.
Is it safe to lose weight during pregnancy on these medicines?
The Zepbound® label is direct here. It states that weight loss offers no benefit during pregnancy and may cause harm. That is why the label advises stopping the medicine when a pregnancy is recognized. Pregnancy is not the time to pursue weight goals with these medicines. Your prescriber can help you focus on healthy support for you and your baby.
When can I restart after pregnancy?
There is no one answer, and your label plus your prescriber decide. Restarting depends on your health, your goals, and whether you are breastfeeding. This page cannot set that timing for you. Bring the question to your care team, and ask them to write down the plan. Keeping the conversation open helps you make a calm, safe choice.
Keep reading
GLP-1 side effects: what to expect
Pregnancy is one of many questions people bring to a GLP-1 medicine. See the fuller picture of common side effects, why they happen, and what tends to help.
Read more →Important: This page is for education only and is not medical advice. Any medicines named here are available by prescription. Always talk to a licensed clinician about medicines, symptoms, or anything you are considering.
Comments